APA

Craver C., Gayle J., Balu S. & Buchner D. (20110929). Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States. : Journal of medical economics.

Chicago

Craver Chris, Gayle Julie, Balu Sanjeev and Buchner Deborah. 20110929. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States. : Journal of medical economics.

Harvard

Craver C., Gayle J., Balu S. and Buchner D. (20110929). Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States. : Journal of medical economics.

MLA

Craver Chris, Gayle Julie, Balu Sanjeev and Buchner Deborah. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States. : Journal of medical economics. 20110929.